Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging (MR-IMPACT-II)

This study has been completed.
Beacon Bioscience, Inc.
Cleveland Clinic Foundation, Cleveland, USA (Corelab for coronary angiography analysis)
CRL, Medinet Europe, Breda, The Netherlands (Corelab for blood sample analyses)
Biomedical Systems
Information provided by:
Amersham Buchler, GmbH & Co KG Identifier:
First received: September 14, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted